Galmed Pharmaceuticals (EOCN) Non Operating Interest Expenses (2014 - 2025)
Galmed Pharmaceuticals (EOCN) posted Non Operating Interest Expenses of -$4,000 for Q3 2025.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Non Operating Interest Expenses (2014 - 2025) Analysis & Trends
For FY2024, Galmed Pharmaceuticals' Non Operating Interest Expenses came in at $1,000, down 83.3% from FY2023.
- Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of -63.0% (FY2019 to FY2024).
- In prior years, Galmed Pharmaceuticals' Non Operating Interest Expenses was $6,000 in FY2023, -$36,000 in FY2022, $6,000 in FY2021 (-96.0%) and $150,000 in FY2020 (+4.2%).
- The Q3 2025 figure stands as the highest quarterly Non Operating Interest Expenses since Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Galmed Pharmaceuticals | 406,071.97 | 406,071.97 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -4,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 206,000.00 |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Mar 31, 2022 | -10,000.00 |
| Mar 31, 2020 | -399,000.00 |
| Mar 31, 2019 | -548,000.00 |
| Dec 31, 2018 | 481,000.00 |
| Sep 30, 2018 | -296,000.00 |
| Jun 30, 2018 | -90,000.00 |
| Mar 31, 2018 | -53,000.00 |
| Dec 31, 2017 | 297,000.00 |
| Sep 30, 2017 | 46,000.00 |
| Jun 30, 2017 | -9,000.00 |
| Mar 31, 2017 | -102,000.00 |
API Access
Galmed Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();